Skip to main content
THE BioMed Co., Ltd. logo

THE BioMed Co., Ltd. — Investor Relations & Filings

Ticker · 214610 ISIN · KR7214610008 KO Manufacturing
Open in API
Filings indexed 446 across all filing types
Latest filing 2026-04-29 Regulatory Filings
Country KR South Korea
Listing KO 214610

About THE BioMed Co., Ltd.

https://www.biomed.co.th/english/

BIOMEDCO is a pharmaceutical company that specializes exclusively in the development and supply of high-grade intravenous (IV) injections. The company is committed to providing reliable pharmaceutical products for medical applications.

Recent filings

Filing Released Lang Actions
[기재정정]주주총회소집결의 (임시주주총회)
Regulatory Filings Classification · 1% confidence The document is a Korean-language notice of convocation (“주주총회소집결의”) for an extraordinary shareholders’ meeting, including a date change correction. It does not contain meeting materials or proxy statements, nor is it a financial or legal report, dividend notice, M&A announcement, or other specific category. It is a standard regulatory announcement of convening a shareholders’ meeting, best mapped to the fallback “Regulatory Filings” category (RNS).
2026-04-29 Korean
금전대여결정
Capital/Financing Update Classification · 1% confidence The document is a regulatory disclosure of a corporate loan decision (“금전대여 결정”) describing the company’s financing activity—loan amount, interest rate, duration, collateral and board resolution details. It is not an annual or interim report, and is not about share issues or dividends. This fits under Capital/Financing Update (CAP) as it details a financing transaction.
2026-04-13 Korean
기타시장안내 (상장폐지 관련 이의신청서 접수 및 개선기간 부여)
Delisting Announcement Classification · 1% confidence The document is an official notice (‘기타시장안내’) regarding a delisting process for the company, detailing the submission of an objection to the delisting and the grant of an improvement period by the exchange. It is not a full financial report but a regulatory announcement about the company’s delisting status. This matches the “Delisting Announcement” category.
2026-04-10 Korean
주권매매거래정지기간변경 (개선기간 부여)
Regulatory Filings Classification · 1% confidence The document is a short exchange notice in Korean regarding a change in the trading suspension period for a listed security (“주권매매거래정지 기간변경”) under KOSDAQ listing rules. It’s not a financial report (10-K, IR, ER, etc.), not a management announcement, and not a dividend or governance statement. It’s a miscellaneous regulatory announcement about trading suspension procedures, so it falls into the generic “Regulatory Filings” category.
2026-04-10 Korean
주주명부폐쇄기간또는기준일설정
Regulatory Filings Classification · 0% confidence The document is a short regulatory announcement in Korean setting the shareholder register closure period (record date) for an extraordinary general meeting. This is not a financial report, proxy statement, or dividend notice, but rather a corporate action notice. It therefore falls under the fallback Regulatory Filings category (RNS).
2026-04-06 Korean
주주총회소집결의 (임시주주총회)
Proxy Solicitation & Information Statement Classification · 1% confidence The document is a formal notice to convene an extraordinary shareholders’ meeting (“임시주주총회”) with date, time, place, record date, board resolution date, and agenda references. It is providing information to shareholders to request their attendance and votes. This matches the definition of a Proxy Solicitation & Information Statement (PSI).
2026-04-06 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.